Research and Development
StemExpress Research and Development
StemExpress is a Contract Research Organization (CRO) that has extensive experience in tissue and human primary cell collection, processing, isolation, cryopreservation, and shipping logistics. Our breadth of knowledge and scientific expertise, as well as our state-of-the-art facilities, enable us to support clients at major universities, research institutes, government agencies, biotechnology and pharmaceutical companies, and contract research organizations (CROs) in the research and development of their cellular products for basic research on into clinical studies.
Examples of past and current collaborations include the development of blood tubes for the recovery of cell-free (cf) DNA and the collection of cancer tumor cells (CTCs) from liquid biopsies, maternal serum kits for the screening of prenatal aneuploidy and pre-eclampsia, and the development and testing of blood separation devices. Read about our Case Studies to learn more.
Our development team collaborates with clients to create and optimize:
- Cell collection protocols
- Cell-based equipment testing
- Blood and specimen kit development
- Research and clinical device development
- Cold chain shipping logistics
“At BioCeryx, StemExpress continues to support our Research and Development projects in a very significant way. The service, speed, and high integrity mode at which StemExpress is able to support our needs plays an important role in facilitating our rapid progress. Without hesitation, I would highly recommend StemExpress to any company, small or large, that depends upon high quality appropriately sourced human research samples.”
-Thomas J. Musci, MD
Chief Medical Officer at BioCeryx
Expect the Highest Quality
StemExpress facilities comply with strict guidelines regarding the production, processing, and management of tissue-based cellular products to ensure the highest quality. Each facility follows current Good Manufacturing Practices (cGMP) regulations covering human cells, tissues, or tissue-based cellular products (HCT/Ps). Our facilities operate under strict, approved standard operating procedures (SOPs) and are managed using Enterprise Resources Planning software (ERP) and 21 CFR Part 11 compliant Quality Management System (QMS), which is used to streamline manufacturing operations from order generation to product delivery. In addition, human tissue collection protocols are approved by the Institutional Review Board (IRB) under 21 CFR Part 50 and 56, as well as our Medical Director.